Block 2 Lecture 5 -- ASDs Flashcards
Indications for phenytoin:
1) focal seizures
2) generalized tonic-clonic
3) emergency status epilepticus
Indications for carbamazepine:
1) temporal lobe epilepsy
2) all others except absence
Indications for oxcarbazepine:
1) temporal lobe epilepsy
2) all others except absence
Indications for valproic acid:
1) absence
2) most others
Indications for lamotrigine:
all seizure types
– including generalized w/ absence attacks in children
Indications for topiramate:
1) focal seizures
2) generalized tonic-clonic
Indications for zonisamide:
1) focal seizures
Indications for lacosamide:
adjunct for focal-onset
Indications for gabapentin
focal seizures
Indications for pregabalin:
same as gabapentin
– focal seizures
Indications for ethosuximide:
absence seizures
Indications for retigabine:
adjunct for focal seizures
Indications for levetiracetam:
1) focal
2) generalized tonic-clonic
Indications for perampanel:
focal seizures
Indications for felbamate:
lennox-gastaut syndrome
retractable epilepsy with uncontrollable seizures
MoA of phenytoin
use-dependent Na+ channel blockade
MoA of carbamazepine
use-dependent Na+ channel blockade
MoA of oxcarbazepine
use-dependent Na+ channel blockade
MoA of lamotrigine
use-dependent Na+ channel blockade
MoA of lacosamide
use-dependent Na+ channel blockade
MoA of valproic acid
1) use-dependent Na+ channel blockade
2) stimulate GABA synthesis
3) inhibit GABA TA
MoA of topiramate
1) use-dependent Na+ channel blockade
2) augment GABA at GABAa
3) blockade of GluR (kainate and AMPA)
MoA of zonisamide
1) use-dependent Na+ channel blockade
2) t-type Ca channel blockade
MoA of Gabapentin
1) Ca channel blocker
2) GABAergic
MoA of pregabalin
Ca channel blocker
MoA of ethosuximide
Ca channel blocker
MoA of retigabine
K channel stabilizer
MoA of levetiracetam
SV2A binder